Science and Technology Science and Technology
Thu, May 27, 2010

Simulations Plus Named aCompany of the Montha by Investment Newsletter


Published on 2010-05-27 05:07:11 - Market Wire
  Print publication without navigation


LANCASTER, Calif.--([ BUSINESS WIRE ])--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software for pharmaceutical discovery and development, today announced that it has been named aCompany of the Montha in the May issue of the investment newsletter The Bowser Report. Now in its 34th year, The Bowser Report is one of the oldest investment newsletters specializing in the analysis of low-priced, small-cap stocks.

"Wea™re pleased and honored to have been selected as aCompany of the Month"

Walt Woltosz, chairman and chief executive officer of Simulations Plus, commented: aWea™re pleased and honored to have been selected as aCompany of the Montha by The Bowser Report. Through the first two quarters of our 2010 fiscal year, we have achieved record highs in our revenues and earnings, shareholder equity has continued to grow, our cash flow is strong, and we continue to have no debt. We believe these gains are the culmination of years of hard work coupled with the broader adoption of simulation technologies by the pharmaceutical industry, and wea™re genuinely grateful to Max Bowser for acknowledging our efforts to the global community of subscribers who follow his investment advice.a

About The Bowser Report

Since 1976, R. Max Bowser has served as editor and publisher of The Bowser Report, a subscription-based newsletter highlighting small-cap stocks trading on the NYSE, NASDAQ, and AMEX at $3.00 per share or less. Companies featured in the publication do not pay for coverage or research nor do they edit the newslettera™s recommendations. For more information or a sample copy, please visit [ http://thebowserreport.com ].

About Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. We have two other businesses that are based on our proprietary technologies: a wholly owned subsidiary, Words+, Inc., which provides assistive technologies to persons with disabilities as well as a personal productivity tool for the mass market called Abbreviate!a"; and FutureLaba", an educational software series for science students in middle and high schools. For more information, please visit our Web sites at [ www.simulations-plus.com ] and [ www.words-plus.com ].

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995a" With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. Our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports as filed with the Securities and Exchange Commission.

Contributing Sources